Macquarie Maintains Outperform on Pediatrix Medical Group, Raises Price Target to $20

Benzinga · 05/08 12:39
Macquarie analyst Tao Qiu maintains Pediatrix Medical Group (NYSE:MD) with a Outperform and raises the price target from $19 to $20.